Industry Representatives

Trusted AI innovation Partners.

Drug Companion AI Software

For Pharma Companies.

Automated AI Diagnostics

For CRO Companies.

Cardiac Implantable Devices Planning

For Medical Devices Companies.

AI compatible with fast scanning sequences

For OEM MRI-Scanners Companies.

Reasons why Industry Representatives choose AI4CMR

Companion for Pharma

AI4CMR is a cloud-based AI tool that automates cardiac MRI analysis, enabling rapid, consistent evaluation of key imaging biomarkers like native T1 and ECV. By streamlining CMR interpretation, it makes advanced cardiac imaging more accessible and scalable. This is especially valuable for cardiac amyloidosis (CA), a frequently underdiagnosed disease caused by amyloid protein buildup in the heart. CMR is a highly sensitive, non-invasive method for detecting and monitoring CA, but its use is limited by time and expertise demands. AI4CMR helps overcome these barriers, supporting earlier diagnosis and better treatment monitoring for both ATTR and AL types of CA.

Automated AI Diagnostics for CROs

AI4CMR is a cloud-based AI platform that automates cardiac MRI analysis, delivering fast, standardized, and scalable interpretation of imaging biomarkers. Designed to integrate seamlessly into clinical research workflows, it enables contract research organizations (CROs) to accelerate imaging-based endpoints, reduce manual variability, and enhance data consistency across multi-site trials. By automating complex post-processing tasks, AI4CMR supports efficient and reproducible cardiac phenotyping, enabling earlier and more accurate AI-assisted diagnosis in cardiovascular studies. This reduces trial timelines, improves data quality, and supports regulatory-grade imaging outcomes—making it a powerful tool for modern, AI-enabled clinical research.

Integration with Intervention Cardiology (Medical devices)

AI4CMR is a cloud-based AI solution that automates cardiac MRI analysis, providing rapid, reproducible insights into cardiac structure and function. For medical device companies, it serves as a powerful tool in clinical development and planning by delivering consistent imaging biomarkers to support device validation, patient selection, and outcome assessment. By integrating AI4CMR into feasibility studies or clinical trials, teams can streamline imaging workflows, reduce variability, and gain deeper, data-driven insights into device performance. This enhances trial efficiency, supports regulatory submissions, and enables faster, evidence-based product development in cardiovascular care.

Interested in reading our whitepapers?

Find out more

AI compatible with OEM fast scanning sequences

AI4CMR is a cloud-native AI platform optimized for compatibility with fast MRI scanning sequences, making it an ideal solution for OEM MRI scanner manufacturers. By enabling automated, high-speed post-processing of cardiac MRI data—including from accelerated sequences like compressed sensing or deep learning-based scans—AI4CMR enhances the value of next-generation hardware. It delivers precise, vendor-neutral image reading and reporting, helping OEMs demonstrate the clinical utility of their advanced imaging technologies. Integrating AI4CMR supports faster scan-to-report workflows, improves usability, and strengthens the competitive positioning of MRI systems in an increasingly AI-driven imaging market.

What our client said

“What really stood out was the responsiveness. Any question we had—technical or clinical—was answered almost immediately. Having a team that knows both the product and the hospital environment made all the difference during onboarding and beyond.”